GLP-1 signals fullness to your brain, helping you reduce food intake, while GIP enhances your body's insulin efficiency and glucose regulation
An intestinal pseudo-obstruction is when a patient appears to have a blockage of the large or small intestine, but in reality, the patients intestinal muscles are not working properly to move food, similar to what was just described for an ileus
1E,F) were measured using an Echo-MRI system
Cardiovascular Outcomes# LEADER Trial (Liraglutide)# The LEADER trial (Marso et al., NEJM 2016) enrolled 9,340 patients with type 2 diabetes and high cardiovascular risk
Studies show that GLP-1-based medications like Semaglutide and Tirzepatide can help individuals lose up to 1522% of their body weight over timebacked by real clinical trials and physician oversight. Whether youve struggled with obesity, metabolic slowdown, or unsuccessful commercial weight loss programs in the past, were here to guide you with science-based support every step of the way